文献库搜索 | GeneLibs

Han(Na),Cheng(Qiao-Yuan),Chen(Bo),Cai(Ju-F... Adv Clin Exp Med 0000-00-00

...PIK3CA) gene, which encodes the p110α catalytic subunit, plays a key role in the activation of AKT downstream signaling ...

Gorges(Tobias M),Kuske(Andra),Röck(Kathari... Clin Chem 0000-00-00

...PIK3CA and MTOR) or cross talks between tumors and immune cells (e.g., CCL4, CXCL2, CXCL9, IL15, IL1B, or IL8).,Multimar...

Sayagués(José María),Corchete(Luís Antonio... Oncotarget 0000-00-00

...PIK3CA, PTEN and EGFR), endocytosis (e.g., the PDGFRA, SMAD2, ERBB3, PML and FGFR2), and the cell cycle (e.g., SMAD2, CC...

Smid(Marcel),Rodríguez-González(F Germán),... Nat Commun 0000-00-00

...PIK3CA, PTEN, CCND1 and CDH1. We find that CCND3 expression levels do not correlate with amplification, while increased ...

Kim(Minchul),Lu(Falong),Zhang(Yi) Cell Rep 0000-00-00

ARID1A is frequently mutated in ovarian clear cell carcinoma (OCCC) and often co-exists with activating mutations of PIK...

Yoh(Kathryn E),Regunath(Kausik),Guzman(Asj... Proc Natl Acad Sci U S A 0000-00-00

...PIK3CA) oncogenes strongly repress expression of ∆Np63α, the predominant p63 isoform in basal mammary epithelial cells. ...

Fumagalli(D),Wilson(T R),Salgado(R),Lu(X),... Ann Oncol 0000-00-00

...PIK3CA, KRAS, AKT1, FGFR3, HRAS and BRAF at frequencies of 41%, 6%, 5%, 2%, 1% and 2%, respectively, and CN amplificatio...

Patnaik(A),Appleman(L J),Tolcher(A W),Papa... Ann Oncol 0000-00-00

...PIK3CA, KRAS, BRAF, and PTEN mutational status and PTEN immunohistochemistry. Whole-body [(18)F]-fluorodeoxyglucose posi...

Patel(Sapan J),Trivedi(Gaurang L),Darie(Co... J Cell Mol Med 0000-00-00

...PIK3CA (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Alpha), MAPK1 (mitogen-activated protein kinas...

Fuentes-Pananá(Ezequiel M),Morales-Sánchez... Curr Cancer Drug Targets 0000-00-00

...PIK3CA, ARID1A and BCOR genes, and amplification of 9p24.1 that harbors the genes for the JAK2, PD-L1 and PD-L2 proteins...